Regulatory T cells (Treg), as members of CD4+ T cells, have garnered extensive attention in
the research of tumor progression. Treg cells have the function of inhibiting the immune …

Background Hepatocellular carcinoma (HCC), the third most prevalent cause of cancer-
related death, is a frequent primary liver cancer with a high rate of morbidity and mortality. T …

Background Head and neck squamous cell carcinoma (HNSCC) is the most common head
and neck cancer and is highly aggressive and heterogeneous, leading to variable prognosis …

Head and neck squamous cell carcinoma (HNSCC), as a complex and variable malignancy,
poses a significant threat to human health. Since the intricate association between HPV and …

Background Current paradigms of anti-tumor therapies are not qualified to evacuate the
malignancy ascribing to cancer stroma's functions in accelerating tumor relapse and …

HBV infection profoundly escalates hepatocellular carcinoma (HCC) susceptibility,
responsible for a majority of HCC cases. HBV-driven immune-mediated hepatocyte …

Background Mast cells, comprising a crucial component of the tumor immune milieu,
modulate neoplastic progression by secreting an array of pro-and antitumorigenic factors …

Background Hepatocellular carcinoma (HCC) is a global health burden with poor prognosis.
Anoikis, a novel programmed cell death, has a close interaction with metastasis and …

Simple Summary According to the latest GLOBOCAN data, head and neck squamous cell
carcinoma (HNSCC) represents the sixth most prevalent human malignancy. Recent studies …

Background Gastric cancer continues to be a significant global healthcare challenge, and its
burden remains substantial. The development of gastric cancer (GC) is closely linked to …